PremiumThe FlyEnveric CEO says company is ‘at the forefront’ of neuroplastogens field Enveric Biosciences Prepares Presentation for February 2025 Psychedelic: Exclusive talk with biotech company Enveric Biosciences PremiumThe FlyEnveric Biosciences trading halted, news pending Enveric Biosciences trading halted, news pending Enveric Biosciences files to sell common stock, warrants, no amount given PremiumThe FlyEnveric in out-licensing deal with MycoMedica Life for EB-002 Is ENVB a Buy, Before Earnings? Enveric Biosciences announces range of patent issuances 
